
Our micro-cap universe ratings mirror those of our small-cap core (i.e., BUY and NEUTRAL), but are based on a proprietary matrix that ranks companies according to five key metrics: 5-year estimated EPS CAGR, 5-year estimated cash flow CAGR, debt-to-cap, PEG ratios and quality of corporate governance.
Proprietary Matrix
| 1 | 2 | 3 | 4 | 5 | |
| Earnings | <=0% | 1%-5% | 6%-10% | 11%-15% | >15% |
| Balance Sheet | >=49% | 31%-40% | 21%-30% | 11%-20% | 0%-10% |
| Cash Flow | <=0 | 0.1%-2.9% | 3.0%-4.9% | 5.0%-7.9% | >8.0% |
| Governance | >=5 | 4 | 3 | 2 | 1 or 0 |
| PEG Valuation | <=1.76x | 1.51x-1.75x | 1.26x-1.50x | 1.01x-1.25x | <=1.00x |
| Combined score: | 18 or greater BUY | ||||
| 17 or less NEUTRAL | |||||
| Earnings | 5-year estimated EPS CAGR |
| Balance Sheet | Total net debt/capital |
| Cash Flow | Free cash flow yield |
| Governance | Number of governance issues |
| PEG Valuation | Based on forward 12-month EPS, 5 year estimated EPS CAGR |
| Governance issues include: |
| Small audit firm (outside of the top six in the ranking by revenue) |
| Audit and audit-related fees account for less than 75% of auditor compensation |
| Change of control agreements (golden parachutes) |
| Multi-tiered board of directors |
| Minority of directors are independent |
| Related party transactions are material |
| Chairman and CEO titles held by the same executive |
| Stock-based anti-takeover measures (poison pills, participating preferred, etc…) |
| Two classes of stock with different voting rights |
| CEO compensation > 10% of pretax profits |
| Active SEC investigation |
| Qualified financial statements |